Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05750056

Dose Systemic Lidocaine Improve the Quality of Recovery After Colorectal Endoscopic Submucosal Dissection

Conditions: Postoperative Recovery

Sex: All
Ages: 18 Years – N/A
Phase: PHASE4
Enrollment: 234
Sponsor: Fujian Provincial Hospital

Location: China

Summary

Endoscopic submucosal dissection (ESD) is a common procedure that requires a long procedural time. Procedure Sedation is commonly provided to alleviate patients' discomfort and facilitate the implementation of procedures. We conducted a prospective study to determine the effect of intravenous infusion of lidocaine in the cognitive domain of the postoperative quality of recovery scale on day 3 after ESD.

Eligibility Criteria

Inclusion Criteria:American Society of Anesthesiologists (ASA) classification I-III;Scheduled for endoscopic colorectal mucosal dissection.Exclusion Criteria:Patient refuses to participate;BMI greater than 30;Allergic or contraindication to study drugs;History of chronic pain and long-term use of analgesic medication;Severe arrhythmia;Hepatic and renal dysfunction;Any other conditions precluded study inclusion, such as cognitive impairment, pregnancy, or inability to communicate in Mandarin Chinese.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05750056). StuddyBuddy aggregates publicly available trial information.